0001209191-21-065463.txt : 20211118 0001209191-21-065463.hdr.sgml : 20211118 20211118162206 ACCESSION NUMBER: 0001209191-21-065463 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211116 FILED AS OF DATE: 20211118 DATE AS OF CHANGE: 20211118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STACK DAVID M CENTRAL INDEX KEY: 0001204788 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35060 FILM NUMBER: 211424693 MAIL ADDRESS: STREET 1: THE MEDICINES CO STREET 2: 8 CAMPUS DRIVE CITY: PARSIPPANY STATE: NJ ZIP: 07054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pacira BioSciences, Inc. CENTRAL INDEX KEY: 0001396814 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510619477 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5401 WEST KENNEDY BOULEVARD STREET 2: SUITE 890 CITY: TAMPA STATE: FL ZIP: 33609 BUSINESS PHONE: 813-553-6680 MAIL ADDRESS: STREET 1: 5 SYLVAN WAY STREET 2: SUITE 300 CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER COMPANY: FORMER CONFORMED NAME: Pacira Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20101029 FORMER COMPANY: FORMER CONFORMED NAME: PACIRA INC DATE OF NAME CHANGE: 20080318 FORMER COMPANY: FORMER CONFORMED NAME: Blue Acquisition Corp DATE OF NAME CHANGE: 20070418 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-11-16 0 0001396814 Pacira BioSciences, Inc. PCRX 0001204788 STACK DAVID M C/O PACIRA BIOSCIENCES, INC. 5 SYLVAN WAY, SUITE 300 PARSIPPANY NJ 07054 1 1 0 0 CEO and Chairman Common Stock 2021-11-16 4 M 0 15000 10.81 A 94085 D Common Stock 97273 I By Three Colleens Investment, LLC Common Stock 18596 I By Stack Schroon Mohawk FLP Common Stock 315 I LCK Investment LLC Stock Option (Right to Buy) 10.81 2021-11-16 4 M 0 15000 0.00 D 2022-06-05 Common Stock 15000 73670 D Includes 129 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021. Mr. Stack and his wife are the owners of each of Three Colleens Investment, LLC and LCK Investment LLC. Mr. Stack is the general partner of Stack Schroon Mohawk FLP. The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months. /s/ Kristen Williams, Attorney-in-Fact 2021-11-18